Clinical trials

Safety Profile of Psilocybin for Cocaine Use Disorder (opens ClinicalTrials.gov in a new tab)

Suspended Early Phase 1 10 participants University of California, Los Angeles

Cocaine Use Disorder

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (opens ClinicalTrials.gov in a new tab)

Withdrawn Phase 2 0 participants Johns Hopkins University

Opioid Use Disorder

Group PACBT for Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants University of California, Los Angeles

Depression - Major Depressive Disorder, Psilocybin, Cognitive Behavioral Therapy

Comparative Effects of Four Brief Breathwork and Mindfulness Interventions on Anxiety and Psychological Flexibility: A 4-Arm RCT (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 240 participants Valencian International University (VIU)

Anxiety, Psychological Flexibility, Stress

Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 100 participants National Institute on Drug Abuse (NIDA)

Cannabis Use Disorder

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 83 participants M.D. Anderson Cancer Center

Psilocybin, Neuropathy

Effectiveness of Heart Rate Variability Biofeedback Training Versus a Meditation Program in Reducing Stress Levels in University Undergraduate Students (opens ClinicalTrials.gov in a new tab)

Withdrawn 0 participants University of Seville

Stress, Anxiety State

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 64 participants University of Alabama at Birmingham

Weight Loss, GLP - 1, Weight Loss Maintenance, Obesity & Overweight

Mindfulness-Based Substance Use Prevention (MINDS-UP) (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 45 participants New York State Psychiatric Institute

Substance Use

Women's Healthy Aging and Menopause; (WHAM) (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 60 participants University of Miami

Meditation, Health Education

Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 86 participants U.S. Army Medical Research and Development Command

PTSD, Post Traumatic Stress Disorder PTSD, Post Traumatic Stress Disorder

Oral and Sublingual Ketamine (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 10 participants Western University, Canada

Major Depression Severe

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants Nautilus Sanctuary

Post-Traumatic Stress Disorder, Adjustment Disorders

Effectiveness of a Sound Bowl Meditation on Caregiver Stress and Anxiety (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 40 participants Ohio State University

Stress, Anxiety

Psilocybin for Treatment of OCD-2 (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants Francisco A Moreno

Obsessive - Compulsive Disorder

Mindfulness in High Risk Pregnancies (opens ClinicalTrials.gov in a new tab)

Not yet recruiting 60 participants University of Alberta

Stress, Anxiety, Depression, Mindfulness

The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 48 participants Manoj Doss

Healthy

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2/3 300 participants COMPASS Pathways

PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms, PTSD, Post Traumatic Stress Disorder

Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP) (opens ClinicalTrials.gov in a new tab)

Suspended Early Phase 1 5 participants University of Wisconsin, Madison

Posttraumatic Stress Disorder

Neural Effects of Intravenous N,N-dimethyltryptamine (DMT) (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 20 participants Jon Dean

Healthy Participants Study

Pregnenolone for Cannabis Use Disorder and Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants University of Texas Southwestern Medical Center

Cannabis Use Disorder, Major Depressive Disorder (MDD)

The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers. (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 50 participants Gabriella Gobbi

Healthy Participants, Placebo - Control, Psilocybin

Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 120 participants University of Wisconsin, Madison

Well-Being, Psychological, Psychedelic Experiences

The Effects of Psilocybin on Social Connectedness (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1 51 participants Yale University

Loneliness, Grief

Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students (opens ClinicalTrials.gov in a new tab)

Recruiting 53 participants University of Alabama, Tuscaloosa

Stress, Anxiety, Physical Activity